Compile Data Set for Download or QSAR
maximum 50k data
Found 309 with Last Name = 'shimizu' and Initial = 'm'
TargetGlutamate receptor 3(RAT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM50289498(3-Hydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxalin-2...)
Affinity DataKi:  60nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetGlutamate receptor 3(RAT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM84949(CAS_3035216 | NSC_3035216 | YM90k)
Affinity DataKi:  84nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50050449(6-Methoxy-7-nitro-1,4-dihydro-pyrido[2,3-b]pyrazin...)
Affinity DataKi:  370nMAssay Description:Compound was tested in vitro for the inhibition of the specific binding of [3H]-Gly to N-methyl-D-aspartate glutamate receptor 1 in rat whole brain m...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(RAT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM50289504(7-Cyano-3-hydroxy-6-nitro-quinoxalin-2-ol anion | ...)
Affinity DataKi:  1.80E+3nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, kainate 1(RAT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM84949(CAS_3035216 | NSC_3035216 | YM90k)
Affinity DataKi:  2.20E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCocaine esterase(Homo sapiens (Human))
Kanazawa University

Curated by ChEMBL
LigandPNGBDBM50131270(2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]prop...)
Affinity DataKi:  2.30E+3nMAssay Description:Inhibition of human recombinant CES2 assessed as compound hydrolysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(RAT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM50289498(3-Hydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxalin-2...)
Affinity DataKi:  4.10E+3nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50053571(1-Hydroxy-7-imidazol-1-yl-6-nitro-1,4-dihydro-quin...)
Affinity DataKi:  4.20E+3nMAssay Description:Binding affinity of the compound towards glycine binding site on NMDA receptor was determined in rat whole brain membrane using strychnine-insensitiv...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50289504(7-Cyano-3-hydroxy-6-nitro-quinoxalin-2-ol anion | ...)
Affinity DataKi:  5.60E+3nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50050450(6,7-Dinitro-1,4-dihydro-pyrido[2,3-b]pyrazine-2,3-...)
Affinity DataKi:  8.00E+3nMAssay Description:Compound was tested in vitro for the inhibition of the specific binding of [3H]-Gly to N-methyl-D-aspartate glutamate receptor 1 in rat whole brain m...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM84949(CAS_3035216 | NSC_3035216 | YM90k)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM84949(CAS_3035216 | NSC_3035216 | YM90k)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50289498(3-Hydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxalin-2...)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50289504(7-Cyano-3-hydroxy-6-nitro-quinoxalin-2-ol anion | ...)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50289498(3-Hydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxalin-2...)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50030674(6-(1H-1-imidazolyl)-7-nitro-1,2,3,4-tetrahydro-2,3...)
Affinity DataKi:  3.70E+4nMAssay Description:Binding affinity of the compound towards glycine binding site on NMDA receptor was determined in rat whole brain membrane using strychnine-insensitiv...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 1(RAT)
Yamanouchi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50207594(2,3-Dihydroxy-6-nitro-benzo[f]quinoxaline-7-sulfon...)
Affinity DataKi: >1.00E+5nMAssay Description:Binding affinity of the compound towards glycine binding site on NMDA receptor was determined in rat whole brain membrane using strychnine-insensitiv...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetParathyroid hormone/parathyroid hormone-related peptide receptor(Homo sapiens (Human))
Chugai Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50318885(CHEMBL525610 | teriparatide)
Affinity DataIC50:  0.0800nMAssay Description:Displacement of 125I-PTH (1 to 15 residues) from human PTHR1 expressed in African green monkey COS7 cell membranes at 300 uM after 90 mins by gamma c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327428( N-(3-{(1R,5S,6r)-3-[3-(4,4-difluoro-1-methoxycycl...)
Affinity DataIC50:  1.30nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327436(N-(3-{(1R,5S,6r)-3-[3-(1-ethoxy-4,4-difluorocycloh...)
Affinity DataIC50:  1.30nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327443(N-{3-[(1R,5S)-6-ethyl-3-azabicyclo[3.1.0]hexan-6-y...)
Affinity DataIC50:  1.30nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288232(2-[2-(carboxymethoxy)-4-(2-{4H,5H,6H,7H-thieno[2,3...)
Affinity DataIC50:  1.40nMAssay Description:Inhibition of Vitronectin binding to GPIIb/IIIIa Vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327429(N-(3-{(1R,5S,6r)-3-[3-(4,4-difluoropiperidin-1-yl)...)
Affinity DataIC50:  1.40nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327426(N-(3-{(1R,5S,6r)-3-[3-(4,4-difluorocyclohexyl)prop...)
Affinity DataIC50:  1.5nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327423( N-(3-{(1R,5S,6r)-6-ethyl-3-[(2-hydroxy-2,3-dihydr...)
Affinity DataIC50:  1.5nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327427(N-(3-{(1R,5S,6r)-3-[3-(4,4-difluorocyclohexyl)prop...)
Affinity DataIC50:  1.60nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327437(N-(3-{(1R,5S,6r)-3-[3-(4,4-difluoropiperidin-1-yl)...)
Affinity DataIC50:  1.70nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327424(N-(3-{(1R,5S,6r)-6-ethyl-3-[(2-hydroxy-2,3-dihydro...)
Affinity DataIC50:  2nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327431(N-(3-{(1R,5S,6r)-3-[3-(3,3-difluoropyrrolidin-1-yl...)
Affinity DataIC50:  2.5nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327433(N-(3-{(1R,5S,6r)-6-ethyl-3-[(2-methoxy-2,3-dihydro...)
Affinity DataIC50:  2.80nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327430(N-(3-{(1R,5S,6r)-3-[3-(3,3-difluoropyrrolidin-1-yl...)
Affinity DataIC50:  2.90nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVitamin D3 receptor(Homo sapiens (Human))
Tokyo Medical And Dental University

Curated by ChEMBL
LigandPNGBDBM50292705((25R)-25-Adamantyl-1alpha,25-dihydroxy-2-methylene...)
Affinity DataIC50:  3nMAssay Description:Antagonist activity at VDR expressed in COS7 cells assessed as inhibition of 1,25-Dihydroxyvitamin D3-induced response by transient transcription ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327438(N-(3-{(1R,5S,6r)-3-[3-(3,3-difluoropiperidin-1-yl)...)
Affinity DataIC50:  3.10nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327432(N-(3-{(1R,5S,6r)-6-ethyl-3-[(2-hydroxy-2,3-dihydro...)
Affinity DataIC50:  3.20nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327425(N-(3-{(1R,5S,6r)-6-ethyl-3-[(2-methoxy-2,3-dihydro...)
Affinity DataIC50:  3.60nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327435(N-(3-{(1R,5S,6r)-3-[(2-ethoxy-2,3-dihydro-1H-inden...)
Affinity DataIC50:  4.10nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327442(N-(3-{(1R,5S,6r)-3-[(5,6-difluoro-2-hydroxy-2,3-di...)
Affinity DataIC50:  4.10nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50466366(CHEMBL4286190)
Affinity DataIC50:  4.40nMAssay Description:Transrepression of recombinant human GAL4-DBD fused RORgammat LBD expressed in HEK293 cells after 20 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327441(N-(3-{(1R,5S,6r)-3-[(2-hydroxy-2,3-dihydro-1H-inde...)
Affinity DataIC50:  4.5nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288220((2-Carboxymethoxy-5-{2-[(4,5,6,7-tetrahydro-thieno...)
Affinity DataIC50:  4.70nMAssay Description:Biotinylated fibrinogen binding to alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288220((2-Carboxymethoxy-5-{2-[(4,5,6,7-tetrahydro-thieno...)
Affinity DataIC50:  4.70nMAssay Description:Inhibition of biotinylated fibrinogen binding to alphaIIb-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
TargetAngiotensin-converting enzyme(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM21642((2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolid...)
Affinity DataIC50:  5nMAssay Description:Inhibition of ACE by fluorometric assayMore data for this Ligand-Target Pair
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327439(N-(3-{(1R,5S,6r)-3-[(2-hydroxy-2,3-dihydro-1H-inde...)
Affinity DataIC50:  5.40nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288227((2-Carboxymethoxy-5-{2-[(5,6,7,8-tetrahydro-4H-thi...)
Affinity DataIC50:  6nMAssay Description:Inhibition of vWF binding to alphaIIb-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50466386(CHEMBL4286603)
Affinity DataIC50:  8.20nMAssay Description:Transrepression of recombinant human GAL4-DBD fused RORgammat LBD expressed in HEK293 cells after 20 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288218((2-Carboxymethoxy-5-{2-[(5,6,7,8-tetrahydro-4H-thi...)
Affinity DataIC50:  8.70nMAssay Description:Inhibition of biotinylated fibrinogen binding to alphaIIb-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50466381(CHEMBL4281750)
Affinity DataIC50:  9.80nMAssay Description:Transrepression of recombinant human GAL4-DBD fused RORgammat LBD expressed in HEK293 cells after 20 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288230((4-Carboxymethoxy-6-{2-[(4,5,6,7-tetrahydro-thieno...)
Affinity DataIC50:  9.80nMAssay Description:Biotinylated fibrinogen binding to alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50466369(CHEMBL4282801)
Affinity DataIC50:  10nMAssay Description:Transrepression of recombinant human GAL4-DBD fused RORgammat LBD expressed in HEK293 cells after 20 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Sanwa Kagaku Kenkyusho

US Patent
LigandPNGBDBM327434(N-(3-{(1R,5S,6r)-6-ethyl-3-[(2-methoxy-2,3-dihydro...)
Affinity DataIC50:  12nMAssay Description:The inhibition ratio of the test substance at the respective concentrations were calculated with setting the reaction value of the well to which DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 309 total ) | Next | Last >>
Jump to: